Cecile Rochette-Egly



  1. di Masi A, Leboffe L, De Marinis E, Pagano F, Cicconi L, Rochette Egly C, et al. Retinoic acid receptors: from molecular mechanisms to cancer therapy. Mol Aspects Med. 2015;41:1-115 pubmed publisher
    ..Moreover, mechanisms through which deregulation of RA signaling pathways ultimately impact on cancer are examined. Finally, the therapeutic effects of retinoids are reported. ..
  2. Rochette Egly C, Germain P. Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs). Nucl Recept Signal. 2009;7:e005 pubmed publisher
    ..Here we will review these mechanisms, focusing on how kinase signaling and the proteasome pathway cooperate to influence the dynamics of RAR transcriptional activity. ..
  3. Rochette Egly C. Retinoic acid signaling and mouse embryonic stem cell differentiation: Cross talk between genomic and non-genomic effects of RA. Biochim Biophys Acta. 2015;1851:66-75 pubmed publisher
    ..This article is part of a Special Issue entitled Linking transcription to physiology in lipodomics. ..
  4. Andriamoratsiresy D, Piskunov A, Lutzing R, Rochette Egly C. PFN2a, a new partner of RAR? in the cytoplasm. Biochem Biophys Res Commun. 2018;495:846-853 pubmed publisher
    ..Consequently, the actin filament network is altered and MEFs adhesion is decreased. This novel role opens novel avenues for the understanding of pathologies characterized by increased levels of cytoplasmic RAR?. ..